These include: Nausea (affecting 2040% of users, usually improving over time) Vomiting, diarrhoea, and constipation Abdominal pain and bloating Reduced appetite (intended effect, but can be excessive) Less common but more serious adverse effects include pancreatitis (inflammation of the pancreas), gallbladder problems including gallstones, and hypoglycaemia (particularly in people also taking diabetes medications)
( 8) BPC-157 Peptide and Muscle Healing A study was conducted on murine models with injured gastrocnemius muscle complex
GLP-1/GIP receptor agonists are not cosmetic weight-loss injections
1 review
[9] Seek urgent medical attention (call 111, contact your GP urgently, or attend A&E) if you develop: Severe, persistent abdominal pain , particularly if it radiates to the back, as this may indicate pancreatitisa rare but serious adverse effect of GLP-1 agonists